X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (17) 17
group emsa-sg (16) 16
clinical neurology (13) 13
index medicus (13) 13
multiple system atrophy (13) 13
neurosciences (12) 12
male (11) 11
female (10) 10
middle aged (10) 10
neurology (10) 10
aged (8) 8
diagnosis (8) 8
multiple system atrophy - pathology (8) 8
parkinsons-disease (8) 8
atrophy (7) 7
multiple system atrophy - physiopathology (7) 7
progressive supranuclear palsy (7) 7
disease progression (6) 6
cohort studies (5) 5
multiple system atrophy - epidemiology (5) 5
natural-history (5) 5
alpha-synuclein (4) 4
dementia (4) 4
glial cytoplasmic inclusions (4) 4
medical and health sciences (4) 4
medicin och hälsovetenskap (4) 4
multiple system atrophy - diagnosis (4) 4
multiple system atrophy - genetics (4) 4
multiple system atrophy - psychology (4) 4
nervous system diseases (4) 4
neurodegenerative diseases (4) 4
neurologi (4) 4
parkinson disease - physiopathology (4) 4
progression (4) 4
prospective studies (4) 4
severity of illness index (4) 4
adult (3) 3
aged, 80 and over (3) 3
ataxia (3) 3
autonomic dysfunction (3) 3
cerebellar ataxia - diagnosis (3) 3
clinical medicine (3) 3
cognitive ability (3) 3
consensus statement (3) 3
europe (3) 3
idiopathic parkinsons-disease (3) 3
klinisk medicin (3) 3
life sciences (3) 3
medical colleges (3) 3
medicine (3) 3
movement disorders (3) 3
multiple system atrophy - complications (3) 3
neurogenesis (3) 3
parkinson's disease (3) 3
prognosis (3) 3
striatonigral degeneration (3) 3
[sdv.spee]life sciences [q-bio]/santé publique et épidémiologie (2) 2
abridged index medicus (2) 2
alkyl and aryl transferases - genetics (2) 2
amyotrophic lateral sclerosis (2) 2
amyotrophic-lateral-sclerosis (2) 2
analysis (2) 2
animals (2) 2
asian continental ancestry group - genetics (2) 2
autonomic nervous system diseases - physiopathology (2) 2
brain (2) 2
brain - pathology (2) 2
cerebellar ataxia (2) 2
cerebellar ataxia - psychology (2) 2
cerebrospinal-fluid (2) 2
clinical trials (2) 2
clinical trials as topic (2) 2
diagnostic-criteria (2) 2
disability evaluation (2) 2
disorders (2) 2
double-blind (2) 2
follow-up studies (2) 2
health-related quality of life (2) 2
health‐related quality of life (2) 2
heart-rate-variability (2) 2
immunohistochemistry (2) 2
inclusion bodies - metabolism (2) 2
inclusion bodies - pathology (2) 2
medical prognosis (2) 2
medicine & public health (2) 2
mesh: aged (2) 2
mesh: disease progression (2) 2
mesh: female (2) 2
mesh: humans (2) 2
mesh: male (2) 2
mesh: middle aged (2) 2
mesh: multiple system atrophy (2) 2
mesh: severity of illness index (2) 2
mesh: supranuclear palsy, progressive (2) 2
mortality (2) 2
msa-c (2) 2
multiple system atrophy - classification (2) 2
multiple system atrophy - drug therapy (2) 2
multiple system atrophy - metabolism (2) 2
multiple-system-atrophy (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Neural Transmission, ISSN 0300-9564, 12/2005, Volume 112, Issue 12, pp. 1677 - 1686
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2013, Volume 12, Issue 3, pp. 264 - 274
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2015, Volume 14, Issue 7, pp. 710 - 719
Journal Article
Brain, ISSN 0006-8950, 2010, Volume 133, Issue 8, pp. 2382 - 2393
Journal Article
Brain, ISSN 0006-8950, 1/2009, Volume 132, Issue 1, pp. 156 - 171
Parkinson plus diseases, comprising mainly progressive supranuclear palsy (PSP) and multiple system atrophy (MSA) are rare neurodegenerative conditions. We... 
Multiple system atrophy | Progressive supranuclear palsy | Randomized controlled trial | Riluzole | Natural history | MULTIPLE SYSTEM ATROPHY | RICHARDSON-OLSZEWSKI-SYNDROME | GROUP EMSA-SG | NINDS NEUROPATHOLOGIC CRITERIA | AMYOTROPHIC-LATERAL-SCLEROSIS | NATURAL-HISTORY | STRIATONIGRAL DEGENERATION | SPORADIC OLIVOPONTOCEREBELLAR ATROPHY | HUNTINGTONS-DISEASE | NEUROSCIENCES | CLINICAL NEUROLOGY | PROGRESSIVE SUPRANUCLEAR PALSY | Neuroprotective Agents - therapeutic use | Parkinson Disease, Secondary - etiology | Severity of Illness Index | Prognosis | Riluzole - adverse effects | Supranuclear Palsy, Progressive - drug therapy | Humans | Middle Aged | Male | Multiple System Atrophy - complications | Psychometrics | Treatment Outcome | Disease Progression | Supranuclear Palsy, Progressive - complications | Epidemiologic Methods | Riluzole - therapeutic use | Female | Multiple System Atrophy - drug therapy | Aged | Multiple System Atrophy - diagnosis | Neuroprotective Agents - adverse effects | Supranuclear Palsy, Progressive - diagnosis | Index Medicus | Abridged Index Medicus | Supranuclear Palsy, Progressive | Neuroprotective Agents | Parkinson Disease, Secondary | Life Sciences | Multiple System Atrophy | Santé publique et épidémiologie | multiple system atrophy | Original | natural history | riluzole | progressive supranuclear palsy | randomized controlled trial
Journal Article
Cellular and Molecular Life Sciences, ISSN 1420-682X, 4/2017, Volume 74, Issue 8, pp. 1485 - 1501
Parkinson’s disease (PD), dementia with Lewy Bodies (DLB), and multiple system atrophy (MSA) are three major synucleinopathies characterized by... 
Life Sciences | Biomedicine, general | Biochemistry, general | Neuron | Life Sciences, general | Oligodendrocyte | Neuronal cytoplasmic inclusions (NCIs) | Glial cytoplasmic inclusions (GCIs) | Glial nuclear inclusions (GNIs) | Cell Biology | MULTIPLE-SYSTEM-ATROPHY | BIOCHEMISTRY & MOLECULAR BIOLOGY | TEMPORAL-LOBE ATROPHY | ALPHA-SYNUCLEIN | MILD COGNITIVE IMPAIRMENT | CELL BIOLOGY | LEWY BODY PATHOLOGY | GROUP EMSA-SG | PARKINSON DISEASE SUBTYPES | MEDIAL PREFRONTAL CORTEX | LONG-TERM POTENTIATION | PROGRESSIVE SUPRANUCLEAR PALSY | Protein Aggregates | Parkinson Disease - pathology | Multiple System Atrophy - pathology | Humans | Lewy Body Disease - pathology | Hippocampus - pathology | Parkinson Disease - physiopathology | Neurogenesis | Synaptic Transmission | Lewy Body Disease - metabolism | Hippocampus - metabolism | Animals | alpha-Synuclein - analysis | Protein Aggregation, Pathological - pathology | Multiple System Atrophy - metabolism | Inclusion Bodies - pathology | Parkinson Disease - metabolism | Multiple System Atrophy - physiopathology | Inclusion Bodies - metabolism | Hippocampus - physiopathology | alpha-Synuclein - metabolism | Protein Aggregation, Pathological - metabolism | Protein Aggregation, Pathological - physiopathology | Lewy Body Disease - physiopathology | Oligomers | Brain | Medical colleges | Neurons | Depression, Mental | Dementia | Neurophysiology | Neurotransmitters | Neurodegeneration | Neurological disorders
Journal Article